Nicolas F Renna
Overview
Explore the profile of Nicolas F Renna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghelfi A, Staffieri G, Del-Sueldo M, Miranda G, Renna N, Quintana R, et al.
Am J Prev Cardiol
. 2025 Mar;
21:100942.
PMID: 40060172
Objectives: Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular...
2.
Ghelfi A, Miranda G, Voto L, Del Sueldo M, Zilberman J, Mondino R, et al.
Hipertens Riesgo Vasc
. 2024 Dec;
PMID: 39721832
Pharmacological management of HDP includes agents supported by extensive evidence ensuring their safety for use. Among those traditionally described in the literature are: alpha-methyldopa, labetalol, and sustained-release nifedipine (NIF-RETARD). These...
3.
Busman D, Schiavone M, Renna N, Almeida S, Pivato E, Mollmann J, et al.
JACC Case Rep
. 2024 Dec;
29(23):102669.
PMID: 39691335
Mortality and morbidity from cardiovascular disease continue to rise along with obesity and other cardiometabolic risk factors, making comprehensive management for cardiometabolic disease (CMD) imperative. Despite available treatments, gaps exist...
4.
Camilletti J, Renna N, Lopez-Santi R, Erriest J, Garcia-Bello E, Araujo J, et al.
Arch Cardiol Mex
. 2024 Mar;
93(Supl 6):1-9.
PMID: 38537217
Background And Objectives: A cross-sectional survey including 38 questions about demography, clinical condition, changes in health habits, and medical treatments for cardiometabolic patients in outpatient follow-up was conducted. From June...
5.
Charchar F, Prestes P, Mills C, Ching S, Neupane D, Marques F, et al.
J Hypertens
. 2023 Sep;
42(1):23-49.
PMID: 37712135
Hypertension, defined as persistently elevated systolic blood pressure (SBP) >140 mmHg and/or diastolic blood pressure (DBP) at least 90 mmHg (International Society of Hypertension guidelines), affects over 1.5 billion people...
6.
Omboni S, Padwal R, Alessa T, Benczur B, Green B, Hubbard I, et al.
Connect Health
. 2022 Mar;
1:7-35.
PMID: 35233563
During the COVID-19 pandemic, telemedicine has emerged worldwide as an indispensable resource to improve the surveillance of patients, curb the spread of disease, facilitate timely identification and management of ill...
7.
Renna N, Diez E, Miatello R
PLoS One
. 2014 Sep;
9(9):e106563.
PMID: 25184237
Background: In this study, we used vidagliptin(V) to examine the role of the DDP-IV, incretin system component, in the activation of different molecular inflammatory cytokines, NF-kB and VCAM-1 to generate...
8.
Renna N, de Las Heras N, Miatello R
Int J Hypertens
. 2013 Aug;
2013:808353.
PMID: 23970958
Vascular remodeling refers to alterations in the structure of resistance vessels contributing to elevated systemic vascular resistance in hypertension. We start with some historical aspects, underscoring the importance of Glagov's...
9.
Renna N, Diez E, Lembo C, Miatello R
Mediators Inflamm
. 2013 Mar;
2013:513251.
PMID: 23476105
The objective of this work was to demonstrate the role of COX-2 enzyme at the vascular in experimental model of metabolic syndrome. SHR male WKY rats were employed; they were...
10.
Vazquez-Prieto M, Renna N, Diez E, Cacciamani V, Lembo C, Miatello R
Am J Hypertens
. 2010 Oct;
24(2):234-40.
PMID: 20885371
Background: Imbalance in adipocytokines secretion is related to the development of metabolic syndrome (MS). In addition, moderate consumption of red wine (RW) decreases the risk of cardiovascular disease. The aim...